Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Findlay

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Molecular and Cellular Endocrinology|December 3, 2014
Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuliNobuaki Ito, Asiri R Wijenayaka, Matthew Prideaux, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 6, 2013
Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2Masakazu Kogawa, Asiri R Wijenayaka, Renee T Ormsby, et al.
Molecular Cancer Therapeutics|October 8, 2009
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancerIrene Zinonos, Agatha Labrinidis, Michelle Lee, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 7, 2010
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivoIrene Zinonos, Agatha Labrinidis, Michelle Lee, et al.
International Journal of Cancer|March 22, 2006
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAILLisa M Butler, Vasilios Liapis, Stelios Bouralexis, et al.
Bone|March 31, 2007
Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3Gerald J Atkins, Paul H Anderson, David M Findlay, et al.
Calcified Tissue International|December 9, 2015
Peroxidase Enzymes Regulate Collagen Biosynthesis and Matrix Mineralization by Cultured Human OsteoblastsMark O DeNichilo, Alexandra J Shoubridge, Vasilios Panagopoulos, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 12, 2011
Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanismGerald J Atkins, Peter S Rowe, Hui P Lim, et al.
Cancer Research|September 23, 2003
Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivoAmanda N Farrugia, Gerald J Atkins, L Bik To, et al.
Injury|May 27, 2017
Postoperative weight bearing and patient reported outcomes at one year following tibial plateau fracturesDominic Thewlis, Francois Fraysse, Stuart A Callary, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Molecular and Cellular Endocrinology|December 3, 2014
Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuliNobuaki Ito, Asiri R Wijenayaka, Matthew Prideaux, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 6, 2013
Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2Masakazu Kogawa, Asiri R Wijenayaka, Renee T Ormsby, et al.
Molecular Cancer Therapeutics|October 8, 2009
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancerIrene Zinonos, Agatha Labrinidis, Michelle Lee, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 7, 2010
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivoIrene Zinonos, Agatha Labrinidis, Michelle Lee, et al.
International Journal of Cancer|March 22, 2006
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAILLisa M Butler, Vasilios Liapis, Stelios Bouralexis, et al.
Bone|March 31, 2007
Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3Gerald J Atkins, Paul H Anderson, David M Findlay, et al.
Calcified Tissue International|December 9, 2015
Peroxidase Enzymes Regulate Collagen Biosynthesis and Matrix Mineralization by Cultured Human OsteoblastsMark O DeNichilo, Alexandra J Shoubridge, Vasilios Panagopoulos, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 12, 2011
Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanismGerald J Atkins, Peter S Rowe, Hui P Lim, et al.
Cancer Research|September 23, 2003
Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivoAmanda N Farrugia, Gerald J Atkins, L Bik To, et al.
Injury|May 27, 2017
Postoperative weight bearing and patient reported outcomes at one year following tibial plateau fracturesDominic Thewlis, Francois Fraysse, Stuart A Callary, et al.
Pageof 11